CORTEX PHARMACEUTICALS INC/DE/ (CORX) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 41 transactions totaling $1.1M, demonstrating a bullish sentiment with $413.8K in net insider flow. The most recent transaction on Aug 28, 2015 involved a purchase of 11,887,779 shares valued at $0.
No significant insider buying has been recorded for CORX in the recent period.
No significant insider selling has been recorded for CORX in the recent period.
Based on recent SEC filings, insider sentiment for CORX is bullish with an Insider Alignment Score of 69/100 and a net flow of $413.8K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at CORTEX PHARMACEUTICALS INC/DE/ (CORX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading CORX stock, having executed 41 transactions in the past 90 days. The most active insider is Value Partners Co., Ltd. Samyang (Executive), who has made 2 transactions totaling $541.2K.
Get notified when executives and directors at CORX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 28, 2015 | S. J. Manuso James | Executive | Purchase | 11,887,779 | $N/A | $0 | |
| Oct 15, 2014 | David Purcell Richard Jr | Executive | Award | 2,000,000 | $N/A | $0 | |
| Sep 3, 2014 | Sapirstein James | Executive | Award | 2,000,000 | $N/A | $0 | |
| Sep 3, 2014 | Macfarlane Katie | Executive | Award | 2,000,000 | $N/A | $0 | |
| Apr 14, 2014 | Lippa Arnold | Executive | Award | 15,000,000 | $N/A | $0 | |
| Apr 14, 2014 | Eliot Margolis Jeff | Executive | Award | 15,000,000 | $N/A | $0 | |
| Apr 14, 2014 | N. Weingarten Robert | Executive | Award | 15,000,000 | $N/A | $0 | |
| Apr 14, 2014 | M. Radin Marc | Executive | Award | 4,000,000 | $N/A | $0 | |
| Jan 21, 2013 | Partners Co., Ltd. Samyang Value | Executive | Sale | 6,765,466 | $0.04 | $270.6K | |
| Jan 21, 2013 | Partners Co., Ltd. Samyang Value | Executive | Purchase | 6,765,466 | $0.04 | $270.6K | |
| Aug 10, 2012 | Letendre Peter | Executive | Award | 684,031 | $N/A | $0 | |
| Aug 10, 2012 | W. Carley David | Executive | Award | 1,899,158 | $N/A | $0 | |
| Aug 10, 2012 | II Management, Llc Origin Ventures | Executive | Other | 24,200,507 | $N/A | $0 | |
| Jun 15, 2012 | Co., Ltd Samyang Optics | Executive | Sale | 30,000 | $0.05 | $1.5K | |
| Jun 14, 2012 | Co., Ltd Samyang Optics | Executive | Sale | 18,975 | $0.05 | $949 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 3 | $744.2K | 69.3% |
Sale(S) | 28 | $330.4K | 30.7% |
Award(A) | 9 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insiders at CORTEX PHARMACEUTICALS INC/DE/ are accumulating shares at an accelerated pace. With 13 insiders making 41 transactions totaling $744.2K in purchases versus $330.4K in sales, the net buying activity of $413.8K signals strong executive confidence. Value Partners Co., Ltd. Samyang (Executive) leads the buying activity with $541.2K in transactions across all time.